ERFO Stock Overview
Engages in the formulation and production of food supplements in Italy.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Laboratorio Farmaceutico Erfo S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.09 |
| 52 Week High | €1.34 |
| 52 Week Low | €0.88 |
| Beta | 1.64 |
| 11 Month Change | 2.36% |
| 3 Month Change | -2.25% |
| 1 Year Change | 3.33% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -39.72% |
Recent News & Updates
Shareholder Returns
| ERFO | IT Personal Products | IT Market | |
|---|---|---|---|
| 7D | -5.2% | 2.1% | 1.7% |
| 1Y | 3.3% | 6.2% | 15.3% |
Return vs Industry: ERFO underperformed the Italian Personal Products industry which returned 6.2% over the past year.
Return vs Market: ERFO underperformed the Italian Market which returned 15.3% over the past year.
Price Volatility
| ERFO volatility | |
|---|---|
| ERFO Average Weekly Movement | 5.5% |
| Personal Products Industry Average Movement | 4.0% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in IT Market | 6.6% |
| 10% least volatile stocks in IT Market | 2.5% |
Stable Share Price: ERFO has not had significant price volatility in the past 3 months.
Volatility Over Time: ERFO's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Italian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 33 | Alessandro Cute | www.erfo.it |
Laboratorio Farmaceutico Erfo S.p.A. engages in the formulation and production of food supplements in Italy. It produces various types of pharmaceutical forms, such as bottles, single-dose vials and bottles, capsules, tablets, and sachets under the Diètnatural and Gianopharma brands, as well as private label brands. The company offers custom formula creation, regulatory advice, graphics, and packaging services.
Laboratorio Farmaceutico Erfo S.p.A. Fundamentals Summary
| ERFO fundamental statistics | |
|---|---|
| Market cap | €9.33m |
| Earnings (TTM) | €590.33k |
| Revenue (TTM) | €5.93m |
15.8x
P/E Ratio1.6x
P/S RatioIs ERFO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ERFO income statement (TTM) | |
|---|---|
| Revenue | €5.93m |
| Cost of Revenue | €3.33m |
| Gross Profit | €2.60m |
| Other Expenses | €2.01m |
| Earnings | €590.33k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.069 |
| Gross Margin | 43.84% |
| Net Profit Margin | 9.95% |
| Debt/Equity Ratio | 5.9% |
How did ERFO perform over the long term?
See historical performance and comparison